Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760870
Development of a Genetic Score as a Response Modifier for Changes in Weight, Body Composition, and Biochemical Parameters in Obese Adults Undergoing a Low-Energy High-Protein Diet InterventionFaculty of Medicine, Gadjah Mada UniversityNot Yet RecruitingNot Applicable
NCT07760870Not Yet Recruiting
Not Applicable
Development of a Genetic Score as a Response Modifier for Changes in Weight, Bod...Faculty of Medicine, Gadj...
NCT07761871
Exercise and Nutritional Intervention in Patients With Melanoma Receiving ImmunotherapyInstitute of Oncology LjubljanaRecruitingNot Applicable
NCT07761871Recruiting
Not Applicable
Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immuno...Institute of Oncology Lju...
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07761078
Jingwanhong for BedsoresFirst Teaching Hospital of Tianjin University of Traditional Chinese MedicineNot Yet Recruiting
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07760246
A Study in Healthy People to Measure How Different Doses of Verducatib Affect the HeartBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07760246Not Yet Recruiting
Phase 1
A Study in Healthy People to Measure How Different Doses of Verducatib Affect th...Boehringer Ingelheim
NCT07760077
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceutical Research and Development Center LTDNot Yet RecruitingPhase 1
NCT07760077Not Yet Recruiting
Phase 1
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceuti...
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07759440
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital Fracture RepairAlexandria UniversityRecruitingNot Applicable
NCT07759440Recruiting
Not Applicable
Clinical Outcomes of Transconjunctival Vs Transcutaneous Approaches in Orbital F...Alexandria University
NCT07760987
Virtual Reality During Periodontal FrenectomyBilecik Seyh Edebali UniversitesiNot Yet RecruitingNot Applicable
NCT07760987Not Yet Recruiting
Not Applicable
Virtual Reality During Periodontal FrenectomyBilecik Seyh Edebali Univ...
NCT07760935
Digital vs Conventional VFR in Post-Orthodontic RetentionZiauddin UniversityNot Yet RecruitingNot Applicable
NCT07760935Not Yet Recruiting
Not Applicable
Digital vs Conventional VFR in Post-Orthodontic RetentionZiauddin University
NCT07761754
The Effect of Hydration on the Prevention of CI-AKI in STEMI Patients Undergoing Primary PCI (Hydro-AKI Trial)Assiut UniversityNot Yet RecruitingNot Applicable
NCT07761754Not Yet Recruiting
Not Applicable
The Effect of Hydration on the Prevention of CI-AKI in STEMI Patients Undergoing...Assiut University
NCT07759518
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian Stimulation in Infertile Women With Polycystic Ovary SyndromeMst.Sumyara KhatunCompletedNot Applicable
NCT07759518Completed
Not Applicable
Letrozole High Dose (10 mg) Compared to Letrozole Low Dose( 5 mg) for Ovarian St...Mst.Sumyara Khatun
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07759999
Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton TherapyUniversity of Wisconsin, MadisonRecruitingNot Applicable
NCT07759999Recruiting
Not Applicable
Clinical Evaluation of a Treatment Planning Software and Oncology Information Sy...University of Wisconsin,...
NCT07760376
Prevalence, Severity of Dysmenorrhea and Effectiveness of Structured Physiotherapy Interventions Among Doctor of Physical Therapy Students: A Randomized Controlled TrialMuhammad Nawaz Sharif University of Agriculture MultanCompletedNot Applicable
NCT07760376Completed
Not Applicable
Prevalence, Severity of Dysmenorrhea and Effectiveness of Structured Physiothera...Muhammad Nawaz Sharif Uni...
NCT07759284
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People's HospitalNot Yet Recruiting
NCT07759284Not Yet Recruiting
—
Endotracheal Tube Intolerance and Respiratory Airflow PerceptionPeking University People'...
NCT07759245
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)Eli Lilly and CompanyNot Yet RecruitingPhase 2
NCT07759245Not Yet Recruiting
Phase 2
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe...Eli Lilly and Company
NCT07761520
Prevention of Ischemia in Aneurysmal Subarachnoid Hemorrhage Through Remote Ischemic PreconditioningCentre Hospitalier Universitaire de NiceNot Yet RecruitingNot Applicable
NCT07761520Not Yet Recruiting
Not Applicable
Prevention of Ischemia in Aneurysmal Subarachnoid Hemorrhage Through Remote Isch...Centre Hospitalier Univer...
NCT07761299
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical LtdNot Yet Recruiting
NCT07761299Not Yet Recruiting
—
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical Ltd
Result Breakdown
Not yet recruiting15 (75%)
Recruiting3 (15%)
Completed2 (10%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)